Evidence map›Paper›PMID 29541226›Full record

ArticleOncology letters2018

SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.

Weijie Gu, Beihe Wang, Fangning Wan, Junlong Wu, Xiaolin Lu, Hongkai Wang, Yao Zhu, Hailiang Zhang, Guohai Shi, Bo Dai and 1 more

Abstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Crosstalk betweenInternational journal of molecular sciences · 2023
    Review
  9. Article
  10. Multi-Omics Analysis ofJournal of personalized medicine · 2021
    Article
  11. Role of Circular RNA in Kidney-Related Diseases.Frontiers in pharmacology · 2021
    Article
  12. Article
  13. SOX4: The unappreciated oncogene.Seminars in cancer biology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. [Expression of transcription factor SOX12 in lung adenocarcinoma and its clinical significance].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2019
    Article
  20. FUS/circ_002136/miR-138-5p/SOX13 feedback loop regulates angiogenesis in Glioma.Journal of experimental & clinical cancer research : CR · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Weijie GuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Beihe WangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Fangning WanDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Junlong WuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Xiaolin LuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Hongkai WangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Yao ZhuDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Hailiang ZhangDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Guohai ShiDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Bo DaiDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sex-determining region Y-box protein (SOX) genes serve an important role in cancer growth and metastasis. The present study aimed to determine the predictive ability of SOX and associated genes identified through molecular network in clear cell renal cell carcinoma (RCC). A total of 505 patients with clear cell RCC from The Cancer Genome Atlas (TCGA) cohorts were collected in this study. The expression profile of SOX and associated genes were obtained from the TCGA RNAseq database. Clinicopathological characteristics, including age, gender, tumor grade, stage, laterality disease-free-survival and overall survival (OS) were collected. Cox's proportional hazards regression model, as well as Kaplan-Meier curves were used to assess the relative factors. Selected genes of SOXs that demonstrated significant associations with OS were further validated in 192 patients from the validation cohort. In the univariate Cox regression model, SOX1, SOX2, SOX6, SOX11, SOX12, SOX13, SOX15, SOX17 and SOX30 expression were predictive in the prognosis of clear cell RCC. Following adjustment for clinical factors, SOX2 [hazard ratio (HR), 1.130; 95% confidence interval (CI), 1.002-1.275), SOX12 (HR, 1.379; 95% CI, 1.060-1.793) and SOX15 (HR, 1.245; 95% CI, 1.063-1.459) remained statistically significant. Furthermore, POU class 5 homeobox 1 (POU5F1), POU2F1 and nuclear receptor subfamily 5 group A member 1 in the gene cluster network analysis associated with SOX2 did not reduce the statistical significance when added to the multivariate analysis. The findings were extended to the Fudan University Shanghai Cancer Center cohort. The results revealed that high SOX2 and SOX12 expression were associated with poor prognosis for OS (log-rank test, all P<0.05). SOX2 and SOX12 were identified as independent prognostic factors of OS in clear cell RCC.

Indexed as

clear cell renal cell carcinomaprognosisSOX12SOX2TCGA

Identifiers

PMID29541226
PMCPMC5835871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.